VXRT (Vaxart) Cyclically Adjusted FCF per Share: $-2.24 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VXRT Vaxart Inc VXRT
50 GF Score
Price $0.60
! 3 Warning Signs
View Full Analysis

What is Vaxart Cyclically Adjusted FCF per Share?

Vaxart VXRT +1.69% 50 Cyclically Adjusted FCF per Share is $-2.24 as of Mar. 2026. GuruFocus rates VXRT with a GF Score™ of 50/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Vaxart's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.010. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-2.24 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 8.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 18.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Vaxart was 51.10% per year. The lowest was -67.30% per year. And the median was 3.90% per year.

As of today (2026-08-05), Vaxart's current stock price is $0.60. Vaxart's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-2.24. Vaxart's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Vaxart was 5.40. The lowest was 0.11. And the median was 0.46.


Vaxart  (OTCPK:VXRT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Vaxart was 5.40. The lowest was 0.11. And the median was 0.46.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Vaxart Cyclically Adjusted FCF per Share Related Terms


Vaxart Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Vaxart's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxart Cyclically Adjusted FCF per Share Chart

Vaxart Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.62 -3.23 -2.55 -2.68 -2.47

Vaxart Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.75 -2.79 -2.84 -2.47 -2.24

VXRT vs VTVT, SPRB, ENGN: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Vaxart's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxart Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxart's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vaxart's Cyclically Adjusted Price-to-FCF falls into.


VXRT
50GF Score
Vaxart Inc VXRT
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxart Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vaxart's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.01/330.2130*330.2130
=-0.010

Current CPI (Mar. 2026) = 330.2130.

Vaxart Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.285 241.018 0.390
201609 -3.046 241.428 -4.166
201612 -2.562 241.432 -3.504
201703 -3.274 243.801 -4.434
201706 0.341 244.955 0.460
201709 -1.281 246.819 -1.714
201712 -1.338 246.524 -1.792
201803 -2.025 249.554 -2.680
201806 0.967 251.989 1.267
201809 -0.775 252.439 -1.014
201812 -0.825 251.233 -1.084
201903 -0.713 254.202 -0.926
201906 -0.033 256.143 -0.043
201909 -0.274 256.759 -0.352
201912 -0.079 256.974 -0.102
202003 -0.053 258.115 -0.068
202006 -0.007 257.797 -0.009
202009 -0.089 260.280 -0.113
202012 -0.106 260.474 -0.134
202103 -0.149 264.877 -0.186
202106 -0.127 271.696 -0.154
202109 -0.126 274.310 -0.152
202112 -0.134 278.802 -0.159
202203 -0.210 287.504 -0.241
202206 -0.223 296.311 -0.249
202209 -0.171 296.808 -0.190
202212 -0.213 296.797 -0.237
202303 -0.190 301.836 -0.208
202306 -0.128 305.109 -0.139
202309 -0.101 307.789 -0.108
202312 -0.095 306.746 -0.102
202403 -0.126 312.332 -0.133
202406 -0.067 314.175 -0.070
202409 -0.019 315.301 -0.020
202412 -0.032 315.605 -0.033
202503 -0.043 319.799 -0.044
202506 -0.069 322.561 -0.071
202509 0.011 324.800 0.011
202512 0.130 324.054 0.132
202603 -0.010 330.213 -0.010

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-2.24 mean?
Vaxart (VXRT) has a Cyclically Adjusted FCF per Share of $-2.24 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Vaxart and its competitors.
Is Vaxart's Cyclically Adjusted FCF per Share too high?
Vaxart's current Cyclically Adjusted FCF per Share is $-2.24. Overall, Vaxart has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Vaxart's Cyclically Adjusted FCF per Share compare to VTVT and SPRB?
Vaxart's Cyclically Adjusted FCF per Share of $-2.24 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Vaxart and its competitors. Vaxart's current Cyclically Adjusted FCF per Share is $-2.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxart stock overvalued right now?
Vaxart (VXRT) has a current Cyclically Adjusted FCF per Share of $-2.24. The current Cyclically Adjusted FCF per Share is $-2.24. Vaxart's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Vaxart (VXRT), the current Cyclically Adjusted FCF per Share is $-2.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxart Business Description

Address 170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically, all the business activity functions through the region of the United States.
50GF Score

Get the complete analysis for VXRT

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price